Adrian V. S. Hill
Fondateur chez Oxxon Therapeutics, Inc.
Relations actives
| Nom | Sexe | Age | Sociétés liées | Collaboration |
|---|---|---|---|---|
| Bernard J. Taylor | M | 67 |
University of Oxford
| - |
| Joerg Schneider | M | - |
Oxxon Therapeutics, Inc.
 Oxxon Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Oxxon Therapeutics, Inc. develops and manufactures antigen-specific immunotherapies to treat patients with chronic infectious diseases and cancer. The company has three development programs in hepatitis, melanoma, and HIV. Oxxon Therapeutics was founded in 1999 by Dr. Joerg Schneider and is located at Oxford, UK. | 25 ans |
| Ian Gardiner | M | - |
University of Oxford
| - |
| John Bell | M | 71 |
Magdalen College School Oxford Ltd
University of Oxford
| 43 ans |
| Chas Bountra | M | 64 |
University of Oxford
| - |
| Sheila Barrett | F | - |
University of Oxford
| - |
| Peter Hunter | M | - |
University of Oxford
| - |
| Anil Razdan | M | 75 |
University of Oxford
| - |
| Jayne Almond | F | 67 |
University of Oxford
| - |
| Ngaire Woods | F | 62 |
University of Oxford
| 14 ans |
| Peter Friend | M | - |
University of Oxford
| - |
| André Finn | M | - |
University of Oxford
| - |
| Jeff Orenstein | M | - |
University of Oxford
| - |
| Katherine Mary Barker | F | 66 |
University of Oxford
| - |
| Judith Patricia Armitage | M | - |
University of Oxford
| - |
| Marcus du Sautoy | M | - |
University of Oxford
| - |
| Robert Fry | M | - |
University of Oxford
| - |
| Malcolm McCulloch | M | - |
University of Oxford
| - |
| Indrajit Wickramasinghe | M | - |
University of Oxford
| - |
| Mike Chalfen | M | - |
University of Oxford
| - |
| Cheryl Musch | F | - |
University of Oxford
| - |
| Ronald Daniel | M | - |
University of Oxford
| - |
| William Scott-Jackson | M | - |
University of Oxford
| - |
| George Radda | M | - |
University of Oxford
| - |
| Robin Hanson | M | - |
University of Oxford
| - |
| Elish Angiolini | F | - |
University of Oxford
| - |
| Stephen MacMahon | M | - |
University of Oxford
| - |
| Li Jin | M | 54 |
University of Oxford
| - |
| Robert MacLaren | M | 57 |
University of Oxford
| - |
| J. Doyne Farmer | M | 72 |
University of Oxford
| - |
| Zhan Feng Cui | M | 62 |
University of Oxford
| - |
| Lars Henrik Fugger | M | 64 |
University of Oxford
| 17 ans |
| David Kerr | M | - |
University of Oxford
| - |
| Maria Damanaki | F | 72 |
University of Oxford
| - |
| Robyn Norton | F | - |
University of Oxford
| - |
| Leonard Charles William Seymour | M | 66 |
University of Oxford
| - |
| Peter Grindrod | M | - |
University of Oxford
| - |
| Hearth Henrietta | F | - |
University of Oxford
| 3 ans |
| Stephen Westaby | M | - |
University of Oxford
| - |
| Matthew David Robson | M | 55 |
University of Oxford
| - |
| Stefan Karl Neubauer | M | - |
University of Oxford
| - |
| Jan Tadeusz Czernuszka | M | - |
University of Oxford
| - |
| Ashok Kumar Bhattacharya | M | 78 |
University of Oxford
| - |
| Stephen Pulman | M | - |
University of Oxford
| - |
| Alan J. Edwards | M | - |
University of Oxford
| - |
| Len Blavatnik | M | 66 |
University of Oxford
| - |
| Geoffrey Hale | M | - |
University of Oxford
| - |
| Leonard W. Seymour | M | - |
University of Oxford
| - |
| Soo Min Yeoh | F | 68 |
University of Oxford
| - |
| Stephen Davies | M | 74 |
University of Oxford
| 28 ans |
| Bill Spitz | M | 72 |
University of Oxford
| - |
| Patrick Pichette | M | 61 |
University of Oxford
| - |
| Tiong Lu Koh | M | 68 |
University of Oxford
| - |
| Herman Waldmann | M | - |
University of Oxford
| - |
| Iain Charles Wilcock | M | 63 |
Oxxon Therapeutics, Inc.
Oxxon Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Oxxon Therapeutics, Inc. develops and manufactures antigen-specific immunotherapies to treat patients with chronic infectious diseases and cancer. The company has three development programs in hepatitis, melanoma, and HIV. Oxxon Therapeutics was founded in 1999 by Dr. Joerg Schneider and is located at Oxford, UK. | - |
| Robert Charles Wigley | M | 63 |
University of Oxford
| - |
| Robert J. Champion de Crespigny | M | - |
University of Oxford
| - |
| Lai Kuen Louey | M | 64 |
University of Oxford
| 13 ans |
| Stephen George Franklin | M | 77 |
University of Oxford
| - |
| Barden N. Gale | M | 73 |
University of Oxford
| - |
| Alan J. Kingsman | M | 73 |
University of Oxford
| - |
| Victor Blank | M | - |
University of Oxford
| - |
| William Castell | M | 76 |
University of Oxford
| - |
| Crispin Davis | M | 75 |
University of Oxford
| - |
| Raj Bhikhu Parekh | M | 63 |
University of Oxford
| - |
| William R. Miller | M | 95 |
University of Oxford
| - |
| David M. Upton | M | 64 |
University of Oxford
| - |
| Anthony Charles Hotson | M | 70 |
University of Oxford
| - |
| André S. Hoffmann | M | 66 |
University of Oxford
| - |
| Peter Ratcliffe | M | 69 |
University of Oxford
| - |
| Geert Linnebank | M | 68 |
University of Oxford
| - |
| E. Kristine Klavers | F | - |
University of Oxford
| - |
| John Hagan Pryce Bayley | M | - |
University of Oxford
| 21 ans |
| Wendy Becker | F | 58 |
University of Oxford
| - |
| Alan Moore | M | - |
University of Oxford
| - |
| Patrick Thomas | M | 67 |
University of Oxford
| - |
| John Martin O'Loan | M | - |
University of Oxford
| - |
| David Kirn | M | 62 |
University of Oxford
| - |
| Marc Feldmann | M | 79 |
University of Oxford
| 13 ans |
| Nigel Shadbolt | M | 68 |
University of Oxford
| - |
| Lionel Tarassenko | M | 67 |
University of Oxford
| 27 ans |
| Michael Sydney Perry | M | - |
University of Oxford
| - |
| Li Jin | M | 53 |
University of Oxford
| 12 ans |
| Benjamine Reid | M | - |
University of Oxford
| - |
| Alex Hawker | M | - |
University of Oxford
| - |
| Julie Baddeley | F | 73 |
University of Oxford
| - |
| Simon Boddie | M | 64 |
University of Oxford
| 3 ans |
| Horace Deets | M | - |
University of Oxford
| - |
| Jeff Scott Garner | M | - |
Oxxon Therapeutics, Inc.
Oxxon Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Oxxon Therapeutics, Inc. develops and manufactures antigen-specific immunotherapies to treat patients with chronic infectious diseases and cancer. The company has three development programs in hepatitis, melanoma, and HIV. Oxxon Therapeutics was founded in 1999 by Dr. Joerg Schneider and is located at Oxford, UK. | - |
| Jane Green | M | - |
University of Oxford
| - |
Graphique Relationnel
Relation dans plusieurs entreprises
Anciennes relations
| Nom | Sexe | Age | Sociétés liées | Collaboration |
|---|---|---|---|---|
| Justin Peter Cobb | M | - |
Magdalen College School Oxford Ltd
| 3 ans |
| Sarah Beshar | F | 65 |
Magdalen College School Oxford Ltd
| 3 ans |
| Dominic Charles Roberts Grieve | M | 68 |
Magdalen College School Oxford Ltd
| 4 ans |
Statistiques
| Pays | Relations | % du total |
|---|---|---|
| Royaume-Uni | 93 | 100,00% |
Age des relations
Actives
Passées
Homme
Femme
Administrateurs
Exécutifs
Provenance des relations
- Bourse
- Insiders
- Adrian V. S. Hill
- Réseau Personnel